Skip to main content

Advertisement

Table 2 Tumor volumes for each group, as defined in Table 1 at 8, 10, 14 and 17 days after implantation of tumors

From: Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity

Group Day 8 Day 10 Day 14 Day 17
1 138.5 ± 37.2 370.3 ± 184.0 1602.0 ± 845.2 4089.1 ± 1341.6a
2 130.9 ± 39.2 282.3 ± 140.9 1320.8 ± 529.0 3149.8 ± 727.0
3 137.1 ± 37.0 308.0 ± 125.8 1207.2 ± 445.5 3081.9 ± 553.0
4 111.2 ± 36.6 294.9 ± 132.2 1095.2 ± 382.6 2901.9 ± 696.2
5 129.8 ± 39.2 275.4 ± 114.1 1306.7 ± 440.3 3194.5 ± 524.5
6 132.6 ± 43.3 264.9 ± 96.2 1181.5 ± 630.9 2742.2 ± 784.6
7 123.4 ± 44.0 261.1 ± 166.3 1057.5 ± 528.6 2473.0 ± 756.5
8 142.2 ± 44.3 225.9 ± 81.8 922.0 ± 303.7 2402.8 ± 562.6
P valueb 0.71 0.24 0.05 0.0001
  1. aMeans of the tumor volume for each group were not significantly different until day 14. ANOVA followed by SNK showed that on Day 14 the tumor volume of group 1 was significantly greater than that of groups 7 and 8 and that on Day 17, the tumor volume of Group 1 was significantly greater than that of all other groups. Group 1 had 20 mice, all other groups had 10 mice.
  2. bP value from the ANOVA. The decreasing p value with time indicates that the differences between groups were increasing with time.
  3. Tumor volume (mm3, mean ± SD).